{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T19:45:07Z","timestamp":1743795907908,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,23]]},"DOI":"10.7759\/cureus.79498","type":"journal-article","created":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T13:57:11Z","timestamp":1740319031000},"source":"Crossref","is-referenced-by-count":1,"title":["GANAB-Associated Severe Autosomal Dominant Polycystic Kidney Disease in an 18-Year-Old Female: A Case Report"],"prefix":"10.7759","author":[{"given":"Gautam","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhawna","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjana","family":"Chandrasekhara Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiran","family":"Kuriakose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall E","year":"2019","unstructured":"Cornec-Le Gall E, Alam A, Perrone RD. Autosomal dominant polycystic kidney disease. Lancet (London). 2019, 393:919-35. 10.1016\/S0140-6736(18)32782-X","journal-title":"Lancet (London)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1053\/j.akdh.2024.07.003","article-title":"Autosomal dominant polycystic kidney disease","volume":"31","author":"Suarez ML","year":"2024","unstructured":"Suarez ML, Titan S, Dahl NK. Autosomal dominant polycystic kidney disease. Adv Kidney Dis Health. 2024, 31:496-503. 10.1053\/j.akdh.2024.07.003","journal-title":"Adv Kidney Dis Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2024.08.008","article-title":"Treatment of autosomal-dominant polycystic kidney disease","volume":"24","author":"Jdiaa SS","year":"2024","unstructured":"Jdiaa SS, Mustafa RA, Yu AS. Treatment of autosomal-dominant polycystic kidney disease. Am J Kidney Dis. 2024, 24:8. 10.1053\/j.ajkd.2024.08.008","journal-title":"Am J Kidney Dis"},{"key":"ref4","article-title":"Polycystic kidney disease, autosomal dominant","author":"Harris PC","year":"2002","unstructured":"Harris PC, Torres VE. Polycystic kidney disease, autosomal dominant. GeneReviews\u00ae [Internet]. Adam MP, Feldman J, Mirzaa GM, et al. (ed): University of Washington, Seattle (WA); 2002. 1993-2025."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2016.05.004","article-title":"Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease","volume":"98","author":"Porath B","year":"2016","unstructured":"Porath B, Gainullin VG, Cornec-Le Gall E, et al.. Mutations in GANAB, encoding the glucosidase II\u03b1 subunit, cause autosomal-dominant polycystic kidney and liver disease. Am J Hum Genet. 2016, 98:1193-207. 10.1016\/j.ajhg.2016.05.004","journal-title":"Am J Hum Genet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"Irazabal MV","year":"2015","unstructured":"Irazabal MV, Rangel LJ, Bergstralh EJ, et al.. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. J Am Soc Nephrol. 2015, 26:160-72. 10.1681\/ASN.2013101138","journal-title":"J Am Soc Nephrol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.12.020","article-title":"Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special considerations for disease-modifying therapy","volume":"78","author":"Chebib FT","year":"2021","unstructured":"Chebib FT, Torres VE. Assessing risk of rapid progression in autosomal dominant polycystic kidney disease and special considerations for disease-modifying therapy. Am J Kidney Dis. 2021, 78:282-92. 10.1053\/j.ajkd.2020.12.020","journal-title":"Am J Kidney Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2012.236","article-title":"Polycystic kidney disease: tolvaptan in ADPKD-TEMPO 3:4 trial results","volume":"9","author":"Kelsey R","year":"2013","unstructured":"Kelsey R. Polycystic kidney disease: tolvaptan in ADPKD-TEMPO 3:4 trial results. Nat Rev Nephrol. 2013, 9:1. 10.1038\/nrneph.2012.236","journal-title":"Nat Rev Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.12.002","article-title":"REPRISE: tolvaptan in advanced polycystic kidney disease","volume":"93","author":"Wyatt CM","year":"2018","unstructured":"Wyatt CM, Le Meur Y. REPRISE: tolvaptan in advanced polycystic kidney disease. Kidney Int. 2018, 93:292-5. 10.1016\/j.kint.2017.12.002","journal-title":"Kidney Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010294.pub3","article-title":"Interventions for preventing the progression of autosomal dominant polycystic kidney disease","volume":"10","author":"St Pierre K","year":"2024","unstructured":"St Pierre K, Cashmore BA, Bolignano D, et al.. Interventions for preventing the progression of autosomal dominant polycystic kidney disease. Cochrane Database Syst Rev. 2024, 10:CD010294. 10.1002\/14651858.CD010294.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfac251","article-title":"Autosomal dominant polycystic kidney disease in young adults","volume":"16","author":"Mart\u00ednez V","year":"2023","unstructured":"Mart\u00ednez V, Furlano M, Sans L, et al.. Autosomal dominant polycystic kidney disease in young adults. Clin Kidney J. 2023, 16:985-95. 10.1093\/ckj\/sfac251","journal-title":"Clin Kidney J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/330681-ganab-associated-severe-autosomal-dominant-polycystic-kidney-disease-in-an-18-year-old-female-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T13:57:13Z","timestamp":1740319033000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/330681-ganab-associated-severe-autosomal-dominant-polycystic-kidney-disease-in-an-18-year-old-female-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,23]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.79498","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,23]]}}}